Form 4 filed by Torley Helen
Torley Helen filed this Form 4 on HALO (HALOZYME THERAPEUTICS, INC.) with 18 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-17 01:33:59 UTC.
- Accession
- 0001159036-26-000147
- Filer
- CIK 1528185
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: HALO · HALOZYME THERAPEUTICS, INC. (CIK 1159036)
- Torley Helen director, officer (PRESIDENT AND CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-12 | M exercised | +20,000 | $18.41 | 787,780 | D |
| Common Stock | 2026-11-12 | S sold | -10,711 | $101.093 | 777,069 | D |
| Common Stock | 2026-11-12 | S sold | -9,289 | $101.494 | 767,780 | D |
| Common Stock | 2026-11-13 | M exercised | +1,552 | $18.41 | 769,332 | D |
| Common Stock | 2026-11-13 | M exercised | +18,448 | $16.65 | 787,780 | D |
| Common Stock | 2026-11-13 | S sold | -7,992 | $100.019 | 779,788 | D |
| Common Stock | 2026-11-13 | S sold | -12,008 | $100.614 | 767,780 | D |
| Common Stock | 2026-11-16 | M exercised | +20,000 | $16.65 | 787,780 | D |
| Common Stock | 2026-11-16 | S sold | -7,283 | $96.848 | 780,497 | D |
| Common Stock | 2026-11-16 | S sold | -4,802 | $97.955 | 775,695 | D |
| Common Stock | 2026-11-16 | S sold | -1,586 | $98.891 | 774,109 | D |
| Common Stock | 2026-11-16 | S sold | -4,897 | $100.096 | 769,212 | D |
| Common Stock | 2026-11-16 | S sold | -1,244 | $101.059 | 767,968 | D |
| Common Stock | 2026-11-16 | S sold | -188 | $101.72 | 767,780 | D |
| Option to Purchase Common Stock derivative | 2026-11-12 | M exercised | -20,000 | $18.41 | 1,552 | D |
| Option to Purchase Common Stock derivative | 2026-11-13 | M exercised | -1,552 | $18.41 | 0 | D |
| Option to Purchase Common Stock derivative | 2026-11-13 | M exercised | -18,448 | $16.65 | 231,770 | D |
| Option to Purchase Common Stock derivative | 2026-11-16 | M exercised | -20,000 | $16.65 | 211,770 | D |